Russell J. Spjut, PharmD

Formulary Frontlines®

05/17/2019

Russel Spjut, PharmD, discusses various treatment options for diabetes, as well as explores the most recent technologies aimed at improving management of the disease.

Russel Spjut, PharmD, discusses...

05/17/2019

First Report Managed Care

Pharmacy Insight

Runaway Drug Price Increases: Unsustainable Price Increases Burden Pharmacy Spending

06/08/2017

Russell J. Spjut , PharmD;

Yearly incremental drug price increases are becoming an unsustainable burden on specialty pharmacy spending.

Yearly incremental drug price...

06/08/2017

First Report Managed Care

Pharmacy Insight

Competition, Preferences Within a New Class of Drugs

11/28/2018

Russell J. Spjut , PharmD;

A few months ago, I wrote an article about my initial impressions of the landscape of calcitonin gene-related peptide (CGRP) receptor antagonists for the treatment of migraines just after the launch of the first drug approved in this class,...

A few months ago, I wrote an...

11/28/2018

First Report Managed Care

Pharmacy Insight

Increasing OTC Drug Availability Could Significantly Decrease Payer Spending

08/30/2018

Russell J. Spjut , PharmD;

Increasing access to medications without a prescription, when properly done, has the potential to positively impact many interested parties.

Increasing access to medications...

08/30/2018

First Report Managed Care

News

The Value of Monotherapies for RA

12/21/2017

Russell J. Spjut , PharmD;

Many novel treatments for rheumatoid arthritis have come to the market recently, giving patients options but leaving payers wondering about efficacy and costs.

Many novel treatments for...

12/21/2017

First Report Managed Care

Department

A Hard Look at the Cost of Cancer Therapy

08/30/2017

Russell J. Spjut , PharmD;

With limited success and skyrocketing costs, it could be time for the United States to take a hard look at the societal impact of current cancer therapy coverage practices. Countries like the United Kingdom and Sweden could provide a starting...

With limited success and...

08/30/2017

First Report Managed Care

Department

Overkill: High Cost Drugs for Common Condition

07/03/2017

Russell J. Spjut , PharmD;

Complex, curative agents have been a godsend for debilitating chronic disease states; however, trends indicate that development of these high-priced drugs for common conditions could have an negative effect.

Complex, curative agents have...

07/03/2017

First Report Managed Care

Formulary Frontlines®

Breakthroughs in ALS Treatment

09/25/2017

Russell J. Spjut , PharmD;

An outpouring of social awareness for amyotrophic lateral sclerosis research has led to the first new drug approved for treatment of the disease in 20 years.

An outpouring of social...

09/25/2017

First Report Managed Care

Formulary Frontlines®

Breakthroughs in Acute Myeloid Leukemia

10/26/2017

Russell J. Spjut , PharmD;

S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs.

S Russell Spjut, PharmD,...

10/26/2017

First Report Managed Care